Hims Launches New Offerings for Men With Low Testosterone (1)

Hims & Hers Health Inc. is launching new offerings for men with low testosterone, marking the telehealth company’s long-awaited move into the fast-growing hormonal health category.

The products expand Hims’ core sexual health franchise amid a slowdown in weight-loss drug sales that has dragged on its stock price in recent months. The company will start with a compounded version of enclomiphene, a drug that’s used off-label to treat low testosterone in men.

Pricing will depend on a patient’s treatment cadence, with a three-month plan costing about $199 per month, according to an internal document viewed by Bloomberg. The company will ...